life science investing Positive Phase 2a Fibromyalgia Results Deliver Pain Reduction in 100% of Patients, Strengthening IP Position and Clinical Trial Strategy
life science investing Successful Maiden Dosing of TRP-8803 (IV-Infused Psilocin) Completed in Global First
US Capital Global Facilitates $50MM Financing to Accelerate Charbone Hydrogen's North American Expansion
